Ping Ji sold $163k of ANL
director at Adlai Nortye Group Ltd.. 10,214 shares at an average of $15.99, traded Sep 29, 2026, filed Oct 1, 2026.
Score components
- +15RoleDirector
- +11Trade size$163k at market
- 0Share of holdings soldSold 7.8% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002129331-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | SOpen-market sale American Depository shares | -214 | $15.77 | $3,375 | 131,453 | 13 d ago |
| Sep 30, 2026 | SOpen-market sale American Depository shares | -5,000 | $16.03 | $80k | 126,453 | 13 d ago |
| Sep 30, 2026 | SOpen-market sale American Depository shares | -5,000 | $15.95 | $80k | 121,453 | 13 d ago |
Related signals
Other insiders at Adlai Nortye Group Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | ANLsell Adlai Nortye Group Ltd. | Ping Ji director | $83k 5,000 shares | -4% | |
| 33Weak | ANLsell Adlai Nortye Group Ltd. | Xiaofeng Ye CFO | $165k 11,667 shares | -7% | |
| 25Weak | ANLsell Adlai Nortye Group Ltd. | Yang Lu CEO | $132 10 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.